Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioAtla (BCAB) Interest & Investment Income (2020 - 2025)

BioAtla (BCAB) has disclosed Interest & Investment Income for 6 consecutive years, with $73000.0 as the latest value for Q4 2025.

  • For Q4 2025, Interest & Investment Income fell 86.82% year-over-year to $73000.0; the TTM value through Dec 2025 reached $839000.0, down 75.1%, while the annual FY2025 figure was $843000.0, 74.98% down from the prior year.
  • Interest & Investment Income hit $73000.0 in Q4 2025 for BioAtla, down from $133000.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $1.7 million in Q3 2023 and bottomed at $73000.0 in Q4 2025.
  • Average Interest & Investment Income over 5 years is $625900.0, with a median of $385000.0 recorded in 2022.
  • Year-over-year, Interest & Investment Income surged 7900.0% in 2021 and then crashed 86.82% in 2025.
  • BioAtla's Interest & Investment Income stood at $96000.0 in 2021, then soared by 990.62% to $1.0 million in 2022, then soared by 56.45% to $1.6 million in 2023, then tumbled by 66.18% to $554000.0 in 2024, then plummeted by 86.82% to $73000.0 in 2025.
  • According to Business Quant data, Interest & Investment Income over the past three periods came in at $73000.0, $133000.0, and $233000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.